Issuance of the 11th Series Stock Acquisition Rights for Employees
First written in FY2018-Q3. 3 of 4 entries say "Restated". Latest entry: FY2020-Q1.
27 other companies' latest entry also says "Restated".
- FY2020-Q1RestatedAnnual report
「Series 11 stock acquisition rights Number of stock acquisition rights: 44 Common shares: 4,400 (Performance-based stock acquisition rights)」
The 11th Series of Stock Acquisition Rights to employees is again confirmed as comprising 44 rights, equivalent to 4,400 common shares. - FY2019-Q2RestatedAnnual report
「Series 11 stock acquisition rights Number of stock acquisition rights: 44 Common shares: 4,400 (Performance-based stock acquisition rights)」
The 11th Series of Stock Acquisition Rights to employees is again confirmed as comprising 44 rights, equivalent to 4,400 common shares. - FY2019-Q1RestatedAnnual report
「Series 11 stock acquisition rights Number of stock acquisition rights: 44 Common shares: 4,400 (Performance-based stock acquisition rights)」
The notes reconfirm that the 11th Series of Stock Acquisition Rights to employees comprises 44 rights, equivalent to 4,400 common shares. - FY2018-Q3First statedAnnual report
「At a meeting of the Board of Directors held on 15 January 2018, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to determine the offering terms for stock acquisition rights to be issued to its employees and to solicit subscribers for the stock acquisition rights.」
The Company resolved to issue 44 of the 11th Series of Stock Acquisition Rights to 1 employee, equivalent to 4,400 common shares. The issue price is ¥3,100 per right, the exercise price is ¥1,627 per share, and the exercise period is from 1 April 2019 to 31 March 2029. The exercise condition is achievement of operating income exceeding ¥1 billion.